Gyre Therapeutics (GYRE) Receivables - Net (2012 - 2026)
Gyre Therapeutics (GYRE) posted Receivables - Net of $27.99 million for Q2 2026, up 11.4% from $25.13 million a year earlier and up 5.3% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Receivables - Net (2012 - 2026) Analysis & Trends
At the end of FY2025, Gyre Therapeutics' Receivables - Net came in at $36.72 million, up 53.2% from FY2024.
- Annual Receivables - Net shows a five-year compound annual growth rate of 61.8% (FY2020 to FY2025).
- In prior years, Gyre Therapeutics' Receivables - Net was $23.96 million in FY2024 (+54.1%), $15.55 million in FY2023 (-9.2%), $17.14 million in FY2022 (+842.6%) and $1.82 million in FY2021 (-45.1%).
- Quarterly Receivables - Net has run from a low of $564,000 in Q1 2022 to a high of $36.72 million in Q4 2025 over five years.
- On a year-over-year basis, Receivables - Net has increased in each of the last seven quarters, with growth averaging 36.2% over the last seven quarters.
- The strongest year-over-year quarter for Receivables - Net in the past five years was Q4 2022, with growth of 842.6%; the weakest was Q4 2021, with a decline of 45.1%.
- According to Business Quant data, Receivables - Net for the three prior quarters was $26.58 million (Q1 2026), $36.72 million (Q4 2025) and $26.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.99 Mn |
| Mar 31, 2026 | 26.58 Mn |
| Dec 31, 2025 | 36.72 Mn |
| Sep 30, 2025 | 26.57 Mn |
| Jun 30, 2025 | 25.13 Mn |
| Mar 31, 2025 | 22.29 Mn |
| Dec 31, 2024 | 23.96 Mn |
| Sep 30, 2024 | 19.49 Mn |
| Jun 30, 2024 | 18.62 Mn |
| Mar 31, 2024 | 15.46 Mn |
| Dec 31, 2023 | 15.55 Mn |
| Mar 31, 2023 | 5.00 Mn |
| Dec 31, 2022 | 17.14 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 5.00 Mn |
| Mar 31, 2022 | 564,000.00 |
| Dec 31, 2021 | 1.82 Mn |
| Sep 30, 2021 | 1.11 Mn |
| Jun 30, 2021 | 1.97 Mn |
| Mar 31, 2021 | 1.01 Mn |
API Access
Gyre Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();